Worth reading
49Recurring
Scored from 5 of 6 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Avoiding a definitive answer
How definitive the wording is.Decision and Details
Frequently Asked Questions and Answers
Decision29 June 2026
Period CoveredPolicies concerning medium- to long-term business operations and the announcement of the CML Phase III trial results during the current fiscal year
Going forwardThe CML Phase III trial is scheduled to conclude around September 2026. Following data lock, analysis and other processes, the results are expected to be announced during the current fiscal year. Any official announcements or developments concerning XPRIZE that require disclosure will be announced promptly.
Reason
The disclosure is intended to strengthen information dissemination to shareholders and ensure fair disclosure.
Impact on Business Performance
Revenue from エイリオン社 is not included in the current fiscal year's earnings forecast. The answers do not guarantee future business performance or the realization of the business initiatives described.
| Item | Details |
|---|---|
| Matter Covered | Frequently Asked Questions and Answers |
| Decision Date | 29 June 2026 |
| Period Covered | Policies concerning medium- to long-term business operations and the announcement of the CML Phase III trial results during the current fiscal year |
| Impact on Business Performance | Revenue from エイリオン社 is not included in the current fiscal year's earnings forecast. The answers do not guarantee future business performance or the realization of the business initiatives described. |
| Reason | The disclosure is intended to strengthen information dissemination to shareholders and ensure fair disclosure. |
| Future plans | The CML Phase III trial is scheduled to conclude around September 2026. Following data lock, analysis and other processes, the results are expected to be announced during the current fiscal year. Any official announcements or developments concerning XPRIZE that require disclosure will be announced promptly. |
Items this document does not state (6)
Decision-Making BodyImplementation DateAmountQuantity / scaleGoverning RuleRelated previous disclosures
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The purpose is to strengthen information dissemination to shareholders and ensure fair disclosure.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.